Cargando…
Measuring serum human epididymis secretory protein autoantibody as an early biomarker of lung cancer
BACKGROUND: Lung cancer (LC) is one of the most common types of malignant tumors and is the most prominent cause of tumor-related death worldwide. LC is a heterogeneous disease caused by somatic cell mutations and dysregulation in several signaling pathways. Understanding these pathways provides the...
Autores principales: | Yang, Bin, Ren, Na, Guo, Bo, Xin, Hua, Yin, Yiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797310/ https://www.ncbi.nlm.nih.gov/pubmed/35117419 http://dx.doi.org/10.21037/tcr.2019.11.50 |
Ejemplares similares
-
Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review
por: Yang, Bin, et al.
Publicado: (2019) -
The Association between Human Epididymis Secretory Protein 4 and Metabolic Syndrome
por: Li, Peng-Fei, et al.
Publicado: (2022) -
Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes
por: Liu, Xingui, et al.
Publicado: (2015) -
Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population
por: Tan, Shubo, et al.
Publicado: (2021) -
Urinary Human Epididymis Secretory Protein 4 as a Useful Biomarker for Subclinical Acute Rejection Three Months after Kidney Transplantation
por: Tajima, Soichiro, et al.
Publicado: (2019)